Clinical trial
The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or…
NCT00214240 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214240 |
|---|---|
| Title | The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease |
| Official title | The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cytomegalovirus |
| Intervention type | Drug |
| Interventions | CMV Immune globulin |
| Enrollment | 28 |
| Start date | Jan 1, 2000 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Jul 26, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: